Evidence map›Paper›PMID 25787950›Full record

ArticleJournal of neurophysiology2015

Human Na(v)1.8: enhanced persistent and ramp currents contribute to distinct firing properties of human DRG neurons.

Chongyang Han, Mark Estacion, Jianying Huang, Dymtro Vasylyev, Peng Zhao, Sulayman D Dib-Hajj, Stephen G Waxman

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Excelsatoxin A-Receptor TMEM233 Modulates Nav1.8.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  10. Review
  11. Review
  12. Sulfolipid-1 fromJournal of neurophysiology · 2026
    Article
  13. Targeting NaInternational journal of molecular sciences · 2026
    Review
  14. Suzetrigine, a NaMolecules (Basel, Switzerland) · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chongyang HanDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Mark EstacionDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Jianying HuangDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Dymtro VasylyevDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Peng ZhaoDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Sulayman D Dib-HajjDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut.
Stephen G WaxmanDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut; and Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, West Haven, Connecticut stephen.waxman@yale.edu.

Funding

Sodium Channels in Spinal Cord Injury, Nerve Injury and Neuropathic PainI01BX000605 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI WAXMAN, STEPHEN · 2009 to 2017
–
BLRD VA I01 BX000605
6 · The paper itself

Abstract

Although species-specific differences in ion channel properties are well-documented, little has been known about the properties of the human Nav1.8 channel, an important contributor to pain signaling. Here we show, using techniques that include voltage clamp, current clamp, and dynamic clamp in dorsal root ganglion (DRG) neurons, that human Na(v)1.8 channels display slower inactivation kinetics and produce larger persistent current and ramp current than previously reported in other species. DRG neurons expressing human Na(v)1.8 channels unexpectedly produce significantly longer-lasting action potentials, including action potentials with half-widths in some cells >10 ms, and increased firing frequency compared with the narrower and usually single action potentials generated by DRG neurons expressing rat Na(v)1.8 channels. We also show that native human DRG neurons recapitulate these properties of Na(v)1.8 current and the long-lasting action potentials. Together, our results demonstrate strikingly distinct properties of human Na(v)1.8, which contribute to the firing properties of human DRG neurons.

Indexed as

AgedAnimalsBiophysicsElectric StimulationFemaleGanglia, SpinalGreen Fluorescent ProteinsHumansIon Channel GatingMaleMembrane PotentialsMiceMice, TransgenicMiddle AgedNAV1.8 Voltage-Gated Sodium ChannelNeuronsenhanced green fluorescent proteinGreen Fluorescent ProteinsNAV1.8 Voltage-Gated Sodium ChannelSCN10A protein, humandorsal root ganglionNav1.8persistent currentramp currentsodium channel

Identifiers

PMID25787950
PMCPMC4432682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.